The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2009;361(19):1914.

Review Article
Molecular Origins of Cancer
PreviousPrevious
Volume 361:1475-1485 October 8, 2009 Number 15
NextNext

DNA Damage, Aging, and Cancer
Jan H.J. Hoeijmakers, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
-PubMed Citation
DNA damage has emerged as a major culprit in cancer and many diseases related to aging. The stability of the genome is supported by an intricate machinery of repair, damage tolerance, and checkpoint pathways that counteracts DNA damage. In addition, DNA damage and other stresses can trigger a highly conserved, anticancer, antiaging survival response that suppresses metabolism and growth and boosts defenses that maintain the integrity of the cell. Induction of the survival response may allow interventions that improve health and extend the life span. Recently, the first candidate for such interventions, rapamycin (also known as sirolimus), has been identified.1 . . . [Full Text of this Article]

DNA Damage and Aging

The Magnitude of DNA Damage

Genome Maintenance

The DNA-Repair Toolbox

Diseases of Nucleotide-Excision Repair

Xeroderma Pigmentosum

Cockayne's Syndrome

Trichothiodystrophy

Progeria, Aging, and the Survival Response

DNA Damage and DNA Maintenance in Cancer

Compromised Genome Maintenance and Cancer Therapy

Summary and Future Perspectives


Source Information

From the Department of Genetics, Cancer Genomics Center, Erasmus University Medical Center, Rotterdam, the Netherlands.

This article (10.1056/NEJMra0804615) was updated on November 4, 2009, at NEJM.org.

Address reprint requests to Dr. Hoeijmakers at the Department of Genetics, Cancer Genomics Center, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands, or at j.hoeijmakers@erasmusmc.nl.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.